Ascendis Pharma A/S Announces Presentation of Preclinical Data for TransCon IL-2 β/γ at AACR Virtual Annual Meeting 2020

    NEXT STORY
    Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II
    PREV STORY
    aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting II
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AnaptysBio Announces Third Quarter 2020 Financial Results and Provides Pipeline Updates

    author_avatar
    NASDAQ Market News

    From USD 922.5 million in 2019, The Global Flu Treatment Market is Predicted to Grow to USD 1,325.0 Million By 2025, Registering a CAGR of 5.3% During the Forecast Period (2020–2025): VynZ Research

    author_avatar
    NASDAQ Market News

    Merus to Present at the 36th Annual J.P. Morgan Healthcare Conference

    UTRECHT, The Netherlands, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology ...

    author_avatar
    NASDAQ Market News